Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutlu Doğan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 23, 2017
Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancerYakup Bozkaya, Mutlu Doğan, Gökmen Umut Erdem, et al.
Mutation Research|December 10, 2023
Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patientsHaktan Bağış Erdem, Mustafa Tarık Alay, Zeynep Özdemir, et al.
The Journal of Breast Health|March 24, 2017
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group ExperienceYeşim Eralp, Leyla Kılıç, Gül Alço, et al.
Leukemia Research|February 8, 2021
IPS-3 Validation in 1012 cases with classical hodgkin lymphomaSemra Paydas, Sahin Laçin, Mutlu Doğan, et al.
Mutation Research|July 15, 2023
Uncommon variants detected via hereditary cancer panel and suggestions for genetic counselingZeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzoğlu, et al.
Clinical Breast Cancer|December 28, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) StudyAlper Türkel, İlknur Deliktaş Onur, Anıl Karakayalı, et al.
Oncology|July 30, 2024
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric CancerGökhan Uçar, Serhat Sekmek, İrfan Karahan, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Studyİlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk, et al.
Clinical Lung Cancer|August 14, 2025
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology GroupTuğba Akın Telli, Ali Murat Tatlı, Özkan Alan, et al.
Scientific Reports|October 9, 2024
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) studyNeslihan Özyurt, Ali Alkan, Burcu Gülbağcı, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 23, 2017
Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancerYakup Bozkaya, Mutlu Doğan, Gökmen Umut Erdem, et al.
Mutation Research|December 10, 2023
Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patientsHaktan Bağış Erdem, Mustafa Tarık Alay, Zeynep Özdemir, et al.
The Journal of Breast Health|March 24, 2017
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group ExperienceYeşim Eralp, Leyla Kılıç, Gül Alço, et al.
Leukemia Research|February 8, 2021
IPS-3 Validation in 1012 cases with classical hodgkin lymphomaSemra Paydas, Sahin Laçin, Mutlu Doğan, et al.
Mutation Research|July 15, 2023
Uncommon variants detected via hereditary cancer panel and suggestions for genetic counselingZeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzoğlu, et al.
Clinical Breast Cancer|December 28, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) StudyAlper Türkel, İlknur Deliktaş Onur, Anıl Karakayalı, et al.
Oncology|July 30, 2024
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric CancerGökhan Uçar, Serhat Sekmek, İrfan Karahan, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Studyİlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk, et al.
Clinical Lung Cancer|August 14, 2025
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology GroupTuğba Akın Telli, Ali Murat Tatlı, Özkan Alan, et al.
Scientific Reports|October 9, 2024
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) studyNeslihan Özyurt, Ali Alkan, Burcu Gülbağcı, et al.
Pageof 3